Risk factor | Comments (where applicable) |
---|---|
Before ICU admission | |
Surgery before ICU admission | Divided into urgent or elective |
Diabetes mellitus | Only insulin-treated patients |
COPD | Defined as the presence of a productive cough or expectoration for more than 90 days per year (but on separate days) and for more than 2 consecutive years, provided that a specific disorder responsible for these symptoms was not present |
Chronic liver disease | With confirmation of the diagnosis by liver biopsy or in patients with signs of portal hypertension, such as oesophageal varices or ascites |
Renal failure | Defined as need for haemodyalisis or peritoneal dialysis at the time of admission to the hospital |
Severe heart failure | Defined as New York Heart Association functional class III or IV heart failure |
Malignancy | Histological evidence required for a diagnosis of solid tumour and definitive diagnosis for the diagnosis of haematological malignancy |
HIV infection | Defined as HIV-positive status |
Neutropenia | Total leucocyte count ≤ 500/mm3 |
Immunosuppression | Altered immune status according to APACHE II criteria [8] or in case of a previous diagnosis (congenital or acquired) |
Transplant recipients | Those patients receiving solid organ or bone marrow transplant |
Chemotherapy | Use of cytotoxic agents for the treatment of a neoplasm or an autoimmune disease within 30 days before ICU admission |
Radiotherapy | Radiation therapy within 30 days before ICU admission |
During ICU stay | |
Presence and duration of catheters | Urinary bladder, venous, or arterial catheter |
Nutrition | Enteral or parenteral nutrition |
Mechanical ventilation | |
Dialysis | |
Use of steroids | Patients treated with a daily dose equivalent to 20 mg prednisone |
Neutropenia | Total leucocyte count ≤ 500/mm3 |
Drug use | Antimicrobial and antifungal agents |